The Effect of Transcranial Direct Stimulation on Cognitive Functions of Healthy Adults
The Effect Of Transcranial Direct Stimulation Applied To The Dorsolateral Prefrontal Cortex And Posterior Parietal Cortex İn Cognitive Function, Mood And Proprioception İn Healthy Adults
Background: Transcranial direct current stimulation(tDCS) has been used to improve cognitive functions in healthy young adults.
Purpose: To investigate the effect of TDCS application on different cortex regions on cognitive function.
Methods: Sixty individuals aged 18-30 were included in the study. The participants were randomly divided into the left dorsolateral prefrontal cortex (Left DLPFC Group)(n=20), the right posterior parietal cortex (Right PPC Group)(n=20), and the sham group (Sham Group)(n=20). tDCS was applied for 20 minutes on weekdays for 2 weeks. The participants were evaluated in terms of cognitive functions with Neuropsychometric Test Battery before and after treatment.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Istanbul, Kalkon, 34000
- Damla Ören
-
Istanbul, Kalkon, 34000
- Medipol Mega Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- being 18-30 years old
Exclusion Criteria:
- alcohol and substance addiction
- previous mental illness
- having mental and cognitive problems
- a history of head trauma
- having cardiovascular disease.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: LEFT DLPFC
The anode electrode of tDCS was applied to the left DLPFC and the cathode electrode was connected to the contralateral shoulder.
|
The intervention protocols were applied using tDCS (Teknofil TESsaNova).
All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays.
All applications were done in the form of 20-minute sessions.
|
|
Aktiv komparator: RİGHT PPC
The anode electrode of tDCS was applied to the right PPC and the cathode electrode was connected to the contralateral shoulder.
|
The intervention protocols were applied using tDCS (Teknofil TESsaNova).
All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays.
All applications were done in the form of 20-minute sessions.
|
|
Sham Comparator: Sham
Placebo was applied by placing the electrodes in the right PPC and left DLPFC without applying current.
|
The intervention protocols were applied using tDCS (Teknofil TESsaNova).
All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays.
All applications were done in the form of 20-minute sessions.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Neuropsychiatric Test Battery
Tidsram: 3 weeks
|
It is a test battery for getting detailed information about general cognitive status.
|
3 weeks
|
|
Beck Depression Scale
Tidsram: 3 weeks
|
It measures the symptoms seen in depression such as emotional, cognitive and motivational. It includes 21 items determine a behavioral feature related to depression. Items are numbered from 0 to 3. The goal is to objectively break down the degree of symptoms. The total score of all answers is calculated as follows: 0 to 9 points: Minimally depressive symptoms 10 to 16 points: Mild depressive symptoms Between 17 and 29 points: Moderate depressive symptoms Between 30 and 63 points: Severe depressive symptoms |
3 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studiestol: Lutfu Hanoglu, PhD, Medipol University
- Huvudutredare: Miray BUDAK, PhD, Medipol University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- tDCS on DLPFC and PPC
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .